Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 | P12268 | 7/20 | 0.77 |
| ▸ | ELANE | P08246 | 4/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.52 |
| ▸ | PPARG | P37231 | 2/20 | 0.51 |
| ▸ | PPARD | Q03181 | 1/20 | 0.51 |
| ▸ | PPARA | Q07869 | 1/20 | 0.51 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.51 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.51 |
| ▸ | ACHE | P22303 | 5/20 | 0.50 |
| ▸ | IMPDH1 | P20839 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hericenone J SCHEMBL29862379 | 1.00 | IMPDH2 (0.77) | IMPDH2ELANEALOX5PPARGPPARD | |
| SCHEMBL30190118 | 0.83 | IMPDH2 (0.54) | IMPDH2ELANEALOX5PPARGPPARD | |
| SCHEMBL12151397 | 0.79 | IMPDH2 (0.65) | IMPDH2ELANEIMPDH1KDM4EALDH1A1 | |
| SCHEMBL29861638 | 0.75 | PPARG (0.58) | IMPDH2ELANEALOX5PPARGPPARD | |
| SCHEMBL29861927 | 0.74 | PPARG (0.48) | IMPDH2ELANEALOX5PPARGPPARD | |
| SCHEMBL30096370 | 0.74 | PPARG (0.48) | IMPDH2ELANEALOX5PPARGPPARD | |
| SCHEMBL29861961 | 0.74 | PPARG (0.48) | IMPDH2ELANEALOX5PPARGPPARD | |
| SCHEMBL29861918 | 0.73 | IMPDH2 (0.56) | IMPDH2PPARGPPARDPPARADNMT1 | |
| SCHEMBL29862095 | 0.73 | IMPDH2 (0.56) | IMPDH2PPARGPPARDPPARADNMT1 | |
| SCHEMBL28699738 | 0.73 | MAOB (0.62) | ALOX5PPARGPPARDPPARADNMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250325610-A1 | Compositions Containing Cannabis and Hericium Extracts for the Improvement of Mental Health and Treatment of CNS Disorders | DrinkBrez, LLC (US) | 2025-10-23 | — | — | US | claimed |
| US-20240374665-A1 | CHILLED JUICE EXTRACTION PROCESSES AND PRODUCTS USING PSYCHEDELIC AND FUNCTIONAL MUSHROOMS | GIRARDI JOSEPH (US) | 2024-11-14 | — | — | US | claimed |
| US-20240164424-A1 | Hericium erinaceus DESIGNATED AS STRAIN M2-102-10 AND COMPOSITIONS, PRODUCTS, AND METHODS THEREOF | JPALMER COLLECTIVE, LLC | 2024-05-23 | — | — | US | claimed |
| WO-2023055860-A1 | CHILLED JUICE EXTRACTION PROCESSES AND PRODUCTS USING PSYCHEDELIC AND FUNCTIONAL MUSHROOMS | GIRARDI JOSEPH (US) | 2023-04-06 | — | — | WO | claimed |
| WO-2022187973-A1 | DOSING REGIMENS OF PHARMACEUTICAL AND NUTRACEUTICAL MUSHROOM AND CANNABIS COMPOSITIONS AND THEIR USE TO TREAT CNS DISORDERS AND IMPROVE MENTAL HEALTH | ALLIED CORP. (CA) | 2022-09-15 | — | — | WO | claimed |
| US-20250325610-A1 | Compositions Containing Cannabis and Hericium Extracts for the Improvement of Mental Health and Treatment of CNS Disorders | DrinkBrez, LLC (US) | 2025-10-23 | — | — | US | disclosed |
| US-20240374665-A1 | CHILLED JUICE EXTRACTION PROCESSES AND PRODUCTS USING PSYCHEDELIC AND FUNCTIONAL MUSHROOMS | GIRARDI JOSEPH (US) | 2024-11-14 | — | — | US | disclosed |
| EP-4401713-A1 | ALIMENTARY-RELATED PARTICLES, PRODUCTION METHODS, AND PRODUCTION APPARATUS | Nulixir Inc. (US) | 2024-07-24 | — | — | EP | disclosed |
| EP-4401711-A1 | STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2024-07-24 | — | — | EP | disclosed |
| EP-4401714-A1 | ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2024-07-24 | — | — | EP | disclosed |
| EP-4401712-A1 | ORAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2024-07-24 | — | — | EP | disclosed |
| US-20240164424-A1 | Hericium erinaceus DESIGNATED AS STRAIN M2-102-10 AND COMPOSITIONS, PRODUCTS, AND METHODS THEREOF | JPALMER COLLECTIVE, LLC | 2024-05-23 | — | — | US | disclosed |
| WO-2023043853-A1 | ORAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2023-03-23 | — | — | WO | disclosed |
| WO-2023043854-A1 | ALIMENTARY-RELATED PARTICLES, PRODUCTION METHODS, AND PRODUCTION APPARATUS | Nulixir Inc. (US) | 2023-03-23 | — | — | WO | disclosed |
| WO-2023043855-A1 | ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2023-03-23 | — | — | WO | disclosed |
| US-20230082651-A1 | STABLE AQUEOUS COMPOSITIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2023-03-16 | — | — | US | disclosed |
| US-20230081296-A1 | STABLE NON-AQUEOUS COMPOSITIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2023-03-16 | — | — | US | disclosed |
| US-20230079480-A1 | STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2023-03-16 | — | — | US | disclosed |
| WO-2022187973-A1 | DOSING REGIMENS OF PHARMACEUTICAL AND NUTRACEUTICAL MUSHROOM AND CANNABIS COMPOSITIONS AND THEIR USE TO TREAT CNS DISORDERS AND IMPROVE MENTAL HEALTH | ALLIED CORP. (CA) | 2022-09-15 | — | — | WO | disclosed |
| WO-2014098306-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DEMENTIA | 대한민국(농촌진흥청장) (KR) | 2014-06-26 | — | — | WO | disclosed |